Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 70
Filtrar
3.
Rev Med Interne ; 32(7): e88-90, 2011 Jul.
Artigo em Francês | MEDLINE | ID: mdl-20851507

RESUMO

Septic arthritis of the pubic symphysis is uncommon, and usually occurs in patients with predisposing conditions (female incontinence surgery, sports). Staphylococcus aureus and Pseudomonas aeruginosa are the main bacteria responsible of these infections. Streptococcal infections of the pubic symphysis are uncommon. We report three cases of streptococcal infections of the pubic symphysis that occurred in the absence of predisposing condition such as surgery or endocarditis. The diagnosis of septic arthritis was difficult, particularly in one patient who underwent an orchidopexy for a suspected of spermatic cord torsion before diagnosis was corrected. All three patients had a favourable outcome after an antibiotic treatment combining amoxicillin and rifampicin. Septic arthritis of the pubic symphysis should be suspected in patients with sudden groin pain, pubic tenderness and fever to avoid traumatic treatments and useless investigations.


Assuntos
Artrite Infecciosa/microbiologia , Sínfise Pubiana/microbiologia , Infecções Estreptocócicas/diagnóstico , Adulto , Idoso , Antibacterianos/uso terapêutico , Artrite Infecciosa/tratamento farmacológico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infecções Estreptocócicas/tratamento farmacológico
5.
Ann Dermatol Venereol ; 136 Suppl 7: S417-25, 2009 Dec.
Artigo em Francês | MEDLINE | ID: mdl-20110057

RESUMO

Among diagnostic progress over the last three years in internal medicine, Antisynthetase Syndrome is now more easily recognised with the diffusion of laboratory tests for research of antibodies against tRNA synthetases (Anti JO1, anti PL7, Anti PL12). In two third of cases, these antibodies are found despite absence of antinuclear antibodies. Hence, we have to search them specifically in patients with polyarthritis associated with myositis, cutaneous manifestations (Raynaud phenomenom and "mechanic'hands") and interstitial lung disease. Discovery of asymptomatic mutation in the L ferritin coding sequence help us to better understand the "unexplained" hyperferritinemia. Initially described by japonese gastroenterologists, auto immune pancreatitis in fact a part of a systemic sclerosing disease with a biochemical hallmark: in crease of a subclass of immunoglobulins G (IgG4). A new pediatric disease due to a deficiency of the interleukin1 receptor antagonist (multifocal aseptic osteitis, periostitis, stomatitis, disseminated pustulosis) help us to better understand unexplained auto inflammatory diseases. The therapeutic progress is primarily due to an explosion of biological therapies, particularly four of them very useful for internists (in an off label use) : Interleukin 1 inhibitors (anakinra, Canakinumab) to treat some auto inflammatory diseases (cryopirin associated periodic syndromes and deficency of interleukin 1 receptor antagonist), monoclonal antibody against interleukin 5 (mepolizumab) to treat some hypereosinophilic syndromes and Churg and Strauss angiitis, interleukin 6 inhibitiors to treat multifocal Castleman's disease and adult Still disease, a monoclonal antibody against vascular endothelial growth factor (Bevacizumab) to treat hereditary hemorrhagic telangiectasia.


Assuntos
Doenças Autoimunes/diagnóstico , Doenças Autoimunes/imunologia , Medicina Interna/tendências , Pustulose Exantematosa Aguda Generalizada/diagnóstico , Pustulose Exantematosa Aguda Generalizada/imunologia , Aminoacil-tRNA Sintetases/imunologia , Anticorpos Monoclonais/uso terapêutico , Artrite/diagnóstico , Artrite/imunologia , Autoanticorpos/imunologia , Doenças Autoimunes/tratamento farmacológico , Doenças Autoimunes/genética , Biomarcadores/metabolismo , Quimioterapia Combinada , Ferritinas/genética , Humanos , Proteína Antagonista do Receptor de Interleucina 1/uso terapêutico , Interleucina-6/antagonistas & inibidores , Sobrecarga de Ferro/diagnóstico , Sobrecarga de Ferro/genética , Doenças Pulmonares Intersticiais/diagnóstico , Doenças Pulmonares Intersticiais/imunologia , Mutação , Miosite/diagnóstico , Miosite/imunologia , Osteíte/diagnóstico , Osteíte/imunologia , Pancreatite/diagnóstico , Pancreatite/imunologia , Periostite/diagnóstico , Periostite/imunologia , Doença de Raynaud/diagnóstico , Doença de Raynaud/imunologia , Estomatite/diagnóstico , Estomatite/imunologia , Síndrome , Resultado do Tratamento
6.
Rev Med Interne ; 28(11): 770-4, 2007 Nov.
Artigo em Francês | MEDLINE | ID: mdl-17629593

RESUMO

INTRODUCTION: Erdheim-Chester disease is a rare non-Langerhans form of histiocytosis. We report the use of combined fluorodeoxyglucose positron emission tomography and computed tomography (18F-FDG PET-CT) in this disease. EXEGESIS: Three men, aged from 55 to 74 years with confirmed Erdheim-Chester disease were included. 18F-FDG PET-CT allowed to detect visceral and vascular involvement of the disease which were overlooked with CT-scan or magnetic resonance imaging: left common carotid and ilio-femoral artery in one patient, coronary, femoral and tibia in the second, aortic, common carotid, femoral and mandibula in the remaining patient. Also, sequential 18F-FDG PET-CT was useful to appreciate treatment efficiency (decrease hyperfixation) and decide treatment modification (interferon alpha). CONCLUSION: 18F-FDG PET-CT combined imaging allows to assess the extent of involvement in Erdheim-Chester disease. 18F-FDG PET-CT may be also a useful tool in the management of Erdheim-Chester disease.


Assuntos
Doença de Erdheim-Chester/diagnóstico por imagem , Idoso , Aorta Torácica/diagnóstico por imagem , Fluordesoxiglucose F18 , Humanos , Masculino , Tomografia por Emissão de Pósitrons , Compostos Radiofarmacêuticos , Tomografia Computadorizada por Raios X
7.
Rev Med Interne ; 26(8): 615-23, 2005 Aug.
Artigo em Francês | MEDLINE | ID: mdl-15990200

RESUMO

SUBJECT: Hypothermia (defined as a core temperature lower than 35 degrees C) may result from accidental causes (exposure to cold, drug intoxications), from endocrine disorders (hypothyroidism), or from central or peripheral neurological disease. Among the causes of spontaneous hypothermia, the place of spontaneous periodic hypothermia or Shapiro's syndrome, of which less than 50 cases in children or adults have been reported, remains unclear. METHODS: Case series of spontaneous hypothermia in adults, from a register of the French Society of Internal Medicine (SNFMI). RESULTS: The ten collected cases of spontaneous hypothermia are heterogeneous. In half of the cases, an often ill-labeled psychiatric illness and/or epilepsy and/or anti-psychotic medication were found contributive. Only 5 cases at best seem to conform to the pattern of spontaneous periodic hypothermia or Shapiro's syndrome (in which agenesis of corpus callosum is typically found). In such cases, the episodes of hypothermia start with profuse hyperhidrosis suggesting a paroxystic reset of the hypothalamic thermostat with a lower temperature set point. In none of the cases was found a significant encephalic lesion. None of the treatment trials with anti-epileptics or cyproheptadine were found useful. Spontaneous hypothermia, whether periodic or not, seems to have an unpredictable course, with long periods of remission, and a benign long-term outcome. CONCLUSIONS: Spontaneous hypothermia is a symptom of likely multifactorial etiology. Even in cases conforming to the definition of Shapiro's syndrome, central nervous system anomalies are not unequivocal. No specific treatment for spontaneous hypothermia, whether periodic or not, can be recommended in the current state of knowledge.


Assuntos
Hipotermia/fisiopatologia , Adulto , Idoso , Feminino , Humanos , Hipotermia/etiologia , Masculino , Pessoa de Meia-Idade , Sistema de Registros , Síndrome
9.
Rev Med Interne ; 24(1): 49-54, 2003 Jan.
Artigo em Francês | MEDLINE | ID: mdl-12614858

RESUMO

INTRODUCTION: Crowned dens syndrome is due to a microcrystalline infringement (hydroxyapatite or calcium pyrophosphate) of the retro-odontoidal ligament of atlas, often leading to the erroneous diagnosis of meningitis or spondylitis. We report on three new cases diagnosed from 1996 to 1999. EXEGESIS: The patients complained of cervicalgies, headaches or fever. The initially evoked diagnoses were meningitis, spondylodiscitis or endocarditis. Clinical exam found meningism and an inflammatory syndrome in all patients. Analysis of the cerebro-spinal fluid realised in two cases was normal. The diagnosis of crowned dens syndrome was assessed in two cases by cervical CT scan of C1/C2. In the third case, chondrocalcinosis of a wrist allowed this diagnosis. We report a probably non fortuitous case of crowned dens syndrome associated with genetic hemochromatosis. A non steroidal anti-inflammatory treatment allowed a dramatic regression of clinical symptoms. CONCLUSION: This entity should be better known; it can mimick numerous diagnosis and be responsible for fever in the long course.


Assuntos
Atlas Cervical/patologia , Condrocalcinose/diagnóstico , Idoso , Idoso de 80 Anos ou mais , Anti-Inflamatórios não Esteroides/uso terapêutico , Pirofosfato de Cálcio , Condrocalcinose/patologia , Diagnóstico Diferencial , Durapatita , Humanos , Masculino , Meningite/diagnóstico , Espondilite/diagnóstico , Tomografia Computadorizada por Raios X
10.
Eur J Clin Microbiol Infect Dis ; 21(10): 739-42, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12415473

RESUMO

Reported here is the case of a patient who spontaneously recovered from hemophagocytic syndrome associated with acute B19 infection and concomitant Epstein-Barr virus reactivation. The previously healthy 37-year-old-man was hospitalized after 10 days of high fever, arthralgia and arthritis and was determined to have hemophagocytic syndrome. Immunoglobulin (Ig) M antibodies to Epstein-Barr virus (EBV) capsid antigen, early antigen and parvovirus B19 (B19) were found. B19 DNA and low-level EBV DNA were detected in bone marrow, serum and peripheral blood mononuclear cells. The patient recovered spontaneously without any treatment. Two months later anti-B19 IgG antibodies were detected, while at 9-month follow-up, anti-B19 IgM antibodies were no longer detectable and B19 DNA had disappeared from serum. To the best of our knowledge, this is the first report of spontaneous resolution of hemophagocytic syndrome associated with acute B19 infection and concomitant EBV reactivation in an otherwise healthy adult.


Assuntos
Infecções por Vírus Epstein-Barr/diagnóstico , Histiocitose de Células não Langerhans/diagnóstico , Infecções por Parvoviridae/diagnóstico , Parvovirus B19 Humano/isolamento & purificação , Doença Aguda , Adulto , Infecções por Vírus Epstein-Barr/complicações , Infecções por Vírus Epstein-Barr/imunologia , Seguimentos , Histiocitose de Células não Langerhans/complicações , Histiocitose de Células não Langerhans/imunologia , Humanos , Imunocompetência , Masculino , Infecções por Parvoviridae/complicações , Infecções por Parvoviridae/imunologia , Remissão Espontânea
12.
Neuroradiology ; 44(4): 355-7, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11914815

RESUMO

Antiphospholipid antibodies (APAs) are circulating immunoglobulins associated with a hypercoagulable state. The antiphospholipid syndrome combines APAs and clinical manifestations, including arterial or venous thromboses and/or recurrent spontaneous fetal loss. The main risk incurred by endovascular treatment of intracranial aneurysms is the occurrence of thromboembolic events. We report two cases of patients with antiphospholipid syndrome who developed thromboembolic complications after the endovascular treatment of unruptured intracranial aneurysms.


Assuntos
Síndrome Antifosfolipídica/complicações , Embolização Terapêutica/efeitos adversos , Aneurisma Intracraniano/terapia , Tromboembolia/etiologia , Adulto , Anticoagulantes/administração & dosagem , Isquemia Encefálica/etiologia , Feminino , Heparina/administração & dosagem , Humanos , Aneurisma Intracraniano/complicações , Pessoa de Meia-Idade , Fatores de Risco
13.
Neuroradiology ; 43(7): 565-6, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11512588

RESUMO

We describe a 50-year-old man with relapsing polychondritis (RP) involving auricular cartilage, uveitis and hearing loss, who had an aneurysm of the anterior cerebral artery. Intracranial aneurysm is a rare manifestation of RP.


Assuntos
Aneurisma Intracraniano/complicações , Imageamento por Ressonância Magnética , Policondrite Recidivante/complicações , Humanos , Aneurisma Intracraniano/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Radiografia , Vasculite do Sistema Nervoso Central/diagnóstico por imagem , Vasculite do Sistema Nervoso Central/patologia
14.
Pathol Biol (Paris) ; 48(5): 467-9, 2000 Jun.
Artigo em Francês | MEDLINE | ID: mdl-10949842

RESUMO

Diagnosing catheter-related bloodstream infections is important but not always easy and a failure to make the diagnosis may have serious consequences. A high rate of unnecessary catheter removal is noted. We retrospectively compared the clinical and usual methods of microbiological diagnoses of catheter-related sepsis to the speed of detection of the catheter versus peripheral blood cultures using the Bact-Alert system. We analyzed 50 files of patients with central indwelling devices: 16 single lumen catheters and 34 implanted ports. Twenty-one catheters were classified as infected, and we observed an earlier positivity of catheter versus peripheral blood in all cases, but significant for 19 patients. According to standard diagnosis methods, 29 catheters were estimated non-infected, a more rapid detection of peripheral culture was reported for 17 specimens and, for another eight patients, the time of detection was equal to blood culture drawn from the catheter. In this group, four discrepancies were recorded with a differential time in favor of sepsis related to catheters ranging from 0.5 to 2 hours. Because of its simplicity and low cost, we believed that this method could be the first step of a diagnosis of catheter-related sepsis and could, therefore, avoid unjustified removal, in particular for the implanted ports for which the diagnostic methods are less codified than for catheters. A prospective study is ongoing; the design of the study focuses only on implanted ports.


Assuntos
Bacteriemia/diagnóstico , Cateterismo/efeitos adversos , Bacteriemia/etiologia , Técnicas Bacteriológicas/economia , Sangue/microbiologia , Custos e Análise de Custo , Humanos , Fatores de Tempo
15.
Rev Med Interne ; 21 Suppl 1: 83s-88s, 2000 Mar.
Artigo em Francês | MEDLINE | ID: mdl-10763209

RESUMO

INTRODUCTION: Antiphospholipid syndrome is the most frequent cause of acquired thrombophilia. Aspirin may have some indications. CURRENT KONWLEDGE AND KEY POINTS: The usefulness of low doses of aspirin is now well demonstrated in the prevention of obstetric complications associated with antiphospholipid antibodies (especially pregnancy loss). When heparin is combined with low-dose aspirin, the recurrent rate of fetal loss is lower than 30%. In patients with arterial or venous thrombosis, there is a high rate of recurrence during the two first years except if high-dose warfarin was used (i.e., INR > or = 3). The association warfarin-aspirin in secondary prevention of thrombosis may be evaluated in prospective studies. It is not so clear in the literature and in our experience that warfarin is superior to aspirin in stroke recurrence prevention in patients with antiphospholipid antibodies, except in Sneddon's syndrome. There are no guidelines in primary thrombosis prevention in patients with antiphospholipid antibodies. In lupus patients, aspirin may not be sufficient after many years of follow-up in preventing a first episode of thrombosis. Prospective studies may be undertaken. Atherosclerotic patients with antiphospholipid antibodies are particularly exposed to the risk of thrombosis after revascularisation or angioplasty and stent implantation. Aspirin may have a place in those patients but these must be evaluated. FUTUR PROSPECTS AND PROJECTS: Except in prevention of obstetric complications, the usefulness of aspirin in patients with antiphospholipid antibodies must be evaluated in prospective studies.


Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Síndrome Antifosfolipídica/tratamento farmacológico , Aspirina/uso terapêutico , Inibidores de Ciclo-Oxigenase/uso terapêutico , Morte Fetal/prevenção & controle , Fibrinolíticos/uso terapêutico , Inibidores da Agregação Plaquetária/uso terapêutico , Complicações na Gravidez/tratamento farmacológico , Trombose/prevenção & controle , Adulto , Anti-Inflamatórios não Esteroides/administração & dosagem , Anticoagulantes/administração & dosagem , Anticoagulantes/uso terapêutico , Síndrome Antifosfolipídica/complicações , Arteriosclerose/prevenção & controle , Aspirina/administração & dosagem , Inibidores de Ciclo-Oxigenase/administração & dosagem , Quimioterapia Combinada , Feminino , Fibrinolíticos/administração & dosagem , Humanos , Masculino , Inibidores da Agregação Plaquetária/administração & dosagem , Gravidez , Prevenção Primária , Recidiva , Fatores de Risco , Varfarina/administração & dosagem , Varfarina/uso terapêutico
17.
Rev Med Interne ; 20(10): 869-74, 1999 Oct.
Artigo em Francês | MEDLINE | ID: mdl-10573723

RESUMO

We report four cases of the side effects of minocycline seen during the last two years in our department. There was one case of drug-related lupus and three cases of hypersensitivity reactions, including one eosinophilic pneumopathy with pericarditis, one nephropathy and one severe, pseudo-infectious episode of high fever, rash, lympadenopathy, hepatitis and eosinophilia. Minocycline is a tetracycline agent widely used for acne therapy in France and all over the world. During the last few years, there has been an increasing number of reports concerning systemic adverse reactions to minocycline, with on the one hand auto-immune disorders (lupus, autoimmune hepatitis, vascularitis with ANCA), occurring after a prolonged course of therapy and reported recently in the last few years, and on the other hand, hypersensitivity reactions (eosinophilic pneumopathies, hepatitis, nephropathies, myocarditis, serum sickness or pseudo-infectious reactions), occurring precociously in the course of therapy, and potentially severe. Although these side effects are uncommon in the context of the high number of patients who have been prescribed the drug, the first-line antibiotic therapy in acne must probably be reconsidered.


Assuntos
Antibacterianos/efeitos adversos , Lúpus Vulgar/induzido quimicamente , Minociclina/efeitos adversos , Adolescente , Adulto , Antibacterianos/uso terapêutico , Hipersensibilidade a Drogas/etiologia , Eosinofilia/induzido quimicamente , Feminino , Humanos , Nefropatias/induzido quimicamente , Pneumopatias/induzido quimicamente , Masculino , Minociclina/uso terapêutico
18.
Rev Med Interne ; 20 Suppl 4: 410s-413s, 1999.
Artigo em Francês | MEDLINE | ID: mdl-10522314

RESUMO

BACKGROUND: The antiphospholipid syndrome was individualized 12 years ago. Treatment was initially based on steroids, immunosuppressive drugs and intravenous immunoglobulin therapy. More recently, several retrospective studies have established that in most clinical conditions therapeutic doses of oral vitamin K antagonists (INR > or = 3) are sufficient to control the disease. THE ROLE OF IMMUNOGLOBULIN THERAPY: However, high dose immunoglobulin therapy is still indicated in a few cases, especially in life-threatening immune peripheral thrombocytopenia, and in recurrent foetal loss: in the latter indication, immunoglobulin therapy alone is efficient in 80% of cases. FUTURE PROSPECTS: Prospective studies are needed to assess the efficacy of intravenous immunoglobulin therapy in neurological complications occurring in spite of anticoagulant therapy, and in the context of repeated foetal losses when antithrombotic therapy with aspirin and subcutaneous heparin has failed.


Assuntos
Síndrome Antifosfolipídica/terapia , Imunoglobulinas Intravenosas/uso terapêutico , Anticoagulantes/uso terapêutico , Síndrome Antifosfolipídica/complicações , Síndrome Antifosfolipídica/imunologia , Fibrinolíticos/uso terapêutico , Humanos , Seleção de Pacientes , Estudos Prospectivos , Estudos Retrospectivos , Trombocitopenia/etiologia , Trombose/etiologia , Resultado do Tratamento , Vitamina K/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA